Mode
Text Size
Log in / Sign up
N/A Completed N=178 Randomized Single-blind Health Services Research

Tobacco Cessation for Veterans With Post Traumatic Stress Disorder (PTSD)

Tobacco Use Cessation · Post Traumatic Stress Disorders
Source: ClinicalTrials.gov NCT00908882 ↗
Enrolled (actual)
178
Serious AEs
0.0%
Results posted
Jun 2015
Primary outcomePrimary: Self-reported Quit Attempts - The Primary Outcome is the Number of Veteran's Who Make a Self-reported Quit Attempt (as Defined as a 24-hour Point Prevalence Rate). — 34; 28 participants

Summary

The goal of this study is to improve the effectiveness of tobacco cessation treatment for veterans with Post Traumatic Stress Disorder (PTSD) through ongoing, integrated care management approach using telehealth and motivational interviewing counseling. Both tobacco dependence and PTSD represent enormous challenges to the Veterans Affairs (VA) healthcare system.

Outcome Measures

OutcomeResultp-value
PRIMARY
Self-reported Quit Attempts - The Primary Outcome is the Number of Veteran's Who Make a Self-reported Quit Attempt (as Defined as a 24-hour Point Prevalence Rate).
24; 31
PRIMARY
Number of Participants Who Progressed Along the Stage of Change Toward Action as Measured by the Transtheoretical Model of Change (Short Form) Questionnaire. This Will Identify Current Stage of Change for Each Subject.
22; 21
PRIMARY
Seven-day Point Prevalence -A Primary Outcome is the Number of Veteran's Who Self-reported Quit Smoking for Seven Days.
21; 20
SECONDARY
Post Traumatic Stress Disorder Checklist
58.4; 62.4
SECONDARY
Geriatric Depression Scale
8.4; 9.8

Eligibility Criteria

Inclusion Criteria

  • Diagnostic and Statistical Manual of Mental Disorders IV criteria (DSM-IV) for diagnosis code 309.81 PTSD
  • Willingness to participate
  • Currently smoking 1 or more cigarettes per day

Exclusion Criteria

  • Use smokeless tobacco, pipes or cigars instead of cigarettes
  • Have imminent risk of suicide or violence
  • Have severe psychiatric symptoms or psychosocial instability likely to prevent participation in protocol (provider will assess appropriateness)
  • Have clinically apparent gross cognitive impairment
  • Unable to connect Health Buddy in home
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00908882). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search